Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.55+0.63 (+4.53%)
Close on Nov 18, 2026Market cap $1.05BP/E –Yield –
Omeros shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Omeros's shares outstanding was 90M at Jun 30, 2026. For fiscal 2025 it was 64M, up 9.2% from the year before. Over ten years it grew 5.4% a year on average. The highest annual figure on record is 64M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64M | +9.2% |
| FY2024 | Dec 31, 2024 | 58M | -7.3% |
| FY2023 | Dec 31, 2023 | 63M | +0.0% |
| FY2022 | Dec 31, 2022 | 63M | +0.6% |
| FY2021 | Dec 31, 2021 | 62M | +9.0% |
| FY2020 | Dec 31, 2020 | 57M | +15.5% |
| FY2019 | Dec 31, 2019 | 50M | +1.9% |
| FY2018 | Dec 31, 2018 | 49M | +6.7% |
| FY2017 | Dec 31, 2017 | 46M | +12.6% |
| FY2016 | Dec 31, 2016 | 40M | +7.7% |
| FY2015 | Dec 31, 2015 | 38M | +13.0% |
| FY2014 | Dec 31, 2014 | 33M | +16.4% |
| FY2013 | Dec 31, 2013 | 29M | +18.2% |
| FY2012 | Dec 31, 2012 | 24M | +8.7% |
| FY2011 | Dec 31, 2011 | 22M | +3.7% |
| FY2010 | Dec 31, 2010 | 21M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 90M | +53.0% |
| Q1 FY2026 | Mar 31, 2026 | 90M | +55.2% |
| Q4 FY2025 | Dec 31, 2025 | 71M | +22.3% |
| Q3 FY2025 | Sep 30, 2025 | 66M | +14.4% |
| Q2 FY2025 | Jun 30, 2025 | 59M | +1.1% |
| Q1 FY2025 | Mar 31, 2025 | 58M | -1.3% |
| Q4 FY2024 | Dec 31, 2024 | 58M | -7.1% |
| Q3 FY2024 | Sep 30, 2024 | 58M | -7.8% |
| Q2 FY2024 | Jun 30, 2024 | 58M | -7.8% |
| Q1 FY2024 | Mar 31, 2024 | 59M | -6.4% |
| Q4 FY2023 | Dec 31, 2023 | 62M | -0.5% |
| Q3 FY2023 | Sep 30, 2023 | 63M | +0.2% |
| Q2 FY2023 | Jun 30, 2023 | 63M | +0.2% |
| Q1 FY2023 | Mar 31, 2023 | 63M | +0.2% |
| Q4 FY2022 | Dec 31, 2022 | 63M | +0.3% |
| Q3 FY2022 | Sep 30, 2022 | 63M | +1.3% |
| Q2 FY2022 | Jun 30, 2022 | 63M | +1.7% |
| Q1 FY2022 | Mar 31, 2022 | 63M | +7.7% |
| Q4 FY2021 | Dec 31, 2021 | 63M | +14.8% |
| Q1 FY2021 | Mar 31, 2021 | 62M | +14.0% |
| Q4 FY2020 | Dec 31, 2020 | 62M | +21.8% |
| Q3 FY2020 | Sep 30, 2020 | 58M | +17.9% |
| Q2 FY2020 | Jun 30, 2020 | 55M | +11.1% |
| Q1 FY2020 | Mar 31, 2020 | 54M | +10.8% |
| Q4 FY2019 | Dec 31, 2019 | 51M | +3.3% |
| Q3 FY2019 | Sep 30, 2019 | 49M | +1.5% |
| Q2 FY2019 | Jun 30, 2019 | 49M | +1.4% |
| Q1 FY2019 | Mar 31, 2019 | 49M | +1.5% |
| Q4 FY2018 | Dec 31, 2018 | 49M | +2.1% |
| Q3 FY2018 | Sep 30, 2018 | 49M | +5.2% |
| Q2 FY2018 | Jun 30, 2018 | 48M | +9.9% |
| Q1 FY2018 | Mar 31, 2018 | 48M | +10.2% |
| Q4 FY2017 | Dec 31, 2017 | 48M | +11.1% |
| Q3 FY2017 | Sep 30, 2017 | 46M | +12.7% |
| Q2 FY2017 | Jun 30, 2017 | 44M | +12.4% |
| Q1 FY2017 | Mar 31, 2017 | 44M | – |
| Q4 FY2016 | Dec 31, 2016 | 43M | – |
| Q3 FY2016 | Sep 30, 2016 | 41M | – |
| Q2 FY2016 | Jun 30, 2016 | 39M | – |
See a number that looks wrong?